Cancer affects approximately 1 in 3 individuals. An individual's susceptibility to cancer is partly determined by environmental exposures and by the combination of inherited cancer susceptibility and resistance genes. Initial mapping of these low penetrance cancer susceptibility genes has been done in the mouse because human low penetrance genes are extremely difficult to find using traditional methods due to heterogeneity and interacting factors. Also, the choice of candidate genes for human association studies can miss the unknown or unexpected. Mouse models also have limitations; it can be difficult to identify causal polymorphisms in the mouse because linkage disequilibrium often extends across several genes. To exploit the strengths of both systems, we outline a cross-species strategy to identify human variants associated with increased cancer risk. This approach uses linkage analysis and haplotyping, allelic imbalance in tumors, and gene expression studies in the mouse, combined with association studies and tumor imbalance studies in humans to identify causal cancer susceptibility variants. Allelic variants in both mouse and human can then be used to better understand the mechanisms behind cancer risk and as targets for intervention.
Albertson, D.G., Ylstra, B., Segraves, R., Collins, C., Dairkee, S.H., Kowbel, D., Kuo, W.-L., Gray, J.W., and Pinkel, D. (2000). Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet25, 144—6.
2.
Balmain, A. (2002). Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell108, 145—52.
3.
Balmain, A., Gray, J., and Ponder, B. (2003). The genetics and genomics of cancer. Nat Genet33(Suppl.), 238—44.
4.
Balmain, A., and Nagase, H. (1998). Cancer resistance genes in mice: models for the study of tumor modifiers. Trends Genet14, 139—44.
5.
Berry, R., Schroeder, J.J., French, A.J., McDonnell, S., Peterson, B.J., Cunningham, J.M., Thibodeau, S.N., and Schaid, D.J. (2000). Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet67, 82—91.
6.
Bischoff, J.R., Anderson, L., Zhu, Y., Mossier, K., Ng, L., Souza, B., Schryver, B., Flanagan, P., Clairvoyant, F., Ginther, C., Chan, C.S., Novotny, M., Slamon, D.J., and Plowman, G.D. (1998). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J17, 3052—65.
7.
Botstein, D., and Risch, N. (2003). Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease . Nat Genet33(Suppl.), 228—37.
8.
Cardon, L.R., and Bell, J.I. (2001). Association study designs for complex diseases . Nat Rev Genet2, 91—9.
9.
Colhoun, H.M., McKeigue, P.M., and Smith, G.D. (2003). Problems of reporting genetic associations with complex outcomes (Review). Lancet361, 865—72.
10.
Collins, C., Rommens, J.M., Kowbel, D., Godfrey, T., Tanner, M., Hwang, S.-I., Polikoff, D., Nonet, G., Cochran, J., Myambo, K., Jay, K.E., Froula, J., Cloutier, T., Kuo, W.-L., Yaswen, P., Dairkee, S., Giovanola, J., Hutchinson, G., Isola, J., Kallioniemi, O.-P., Palazzolo, M., Martin, C., Ericsson, C., Pinkel, D., Albertson, D., Li, W.-B., and Gray, J.W. (1998). Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA95, 8703—8.
11.
Dahlman, I., Eaves, I.A., Kosoy, R., Morrison, V.A., Heward, J., Gough, S.C., Allahabadia, A., Franklyn, J.A., Tuomilehto, J., Tuomilehto-Wolf, E., Cucca, F., Guja, C., Ionescu-Tirgoviste, C., Stevens, H., Carr, P., Nutland, S., McKinney, P., Shield, J.P., Wang, W., Cordell, H.J., Walker, N., Todd, J.A., and Concannon, P. (2002). Parameters for reliable results in genetic association studies in common disease. Nat Genet30, 149—50.
12.
Ewart-Toland, A.E., Briassouli, P., de Koning, J.P., Mao, J.-H., Yuan, J., Chan, F., MacCarthy-Morrogh, L., Ponder, P.A.J., Nagase, H., Burns, J., Ball, S., Almeida, M., Linardopoulous, S., and Balmain, A. (2003). Identification of Stk6/STK15 as a candidate modifier of cancer risk in mouse and man. Nat Genet34, 403—12.
13.
Fijneman, R., de Vries, S., Jansen, R., and Demant, P. (1996). Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet14, 465—7.
14.
Frankel, W.M. (1995). Taking stock of complex trait genetics in mice . Trends Genet11, 471—7.
15.
Hirschhorn, J.N., Lohmueller, K., Byrne, E., and Hirshhorn, K. (2002). A comprehensive review of genetic association studies. Genet Med4, 45— 61.
16.
Iakoubova, O.A., Olsson, C.L., Dains, K.M., Ross, D.A., Andalibi, A., Lau, K., Choi, J., Kalcheva, I., Cunanan, M., Louie, J., Nimon, V., Machrus, M., Bentley, L.G., Beauheim, C., Silvey, S., Cavalcoli, J., Lusis, A.J., and West, D.B. (2001). Genome-tagged mice (GTM): two sets of genome-wide congenic strains. Genomics74, 89—104.
17.
Iwabuchi, H., Sakmoto, M., Sakunaga, H., May, Y.-Y., Carcangiu, M.L., Pinkel, D., Yang-Feng, T.L., and Gray, J.W. (1995). Genetic analysis of benign, low-grade and high-grade ovarian tumors. Cancer Res55, 6172— 80.
18.
Kallioniemi, A., Kallioniemi, O.P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H.S., Pinkel, D., Gray, J.W., and Waldman, F.M. (1994). Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA91, 2156—60.
19.
Korn, W.M., Yasutake, T., Kuo, W.L., Warren, R.S., Collins, C., Tomita, M., Gray, J., and Waldman, F.M. (1999). Chromosome arm 20q gains and other genomic alterations incolorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes, Chromosomes, and Cancer25, 82—90.
20.
Korstanje, R., and Paigen, B. (2002). From QTL to gene: the harvest begins. Nat Genet31, 235—6.
21.
Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S., and Hirschhorn, J.N. (2003). Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet33, 177—82.
22.
Nadeau, J.H., Singer, J.B., Matin, A., and Lander, E.S. (2000). Analysing complex genetic traits with chromosome substitution strains. Nat Genet24, 221—5.
23.
Nagase, H., Bryson, S., Cordell, H., Kemp, C.J., Fee, F., and Balmain, A. (1995). Distinct genetic loci control development of benign and malignant skin tumors in mice. Nat Genet10, 424—9.
24.
Nagase, H., Mao, J.H., and Balmain, A. (2003). Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res63, 4849—53.
25.
Nagase, H., Mao, J.-H., and Balmain, A. (1999). A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. Proc Natl Acad Sci USA96, 15032—7.
26.
Nagase, H., Mao, J.-H., de Koning, J.P., Minami, T., and Balmain, A. (2001). Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice. Cancer Res61, 1305—8.
27.
Pharoah, P.D.P., Antoniou, A., Bobrow, M., Zimmern, R.L., Easton, D.F., and Ponder, B.A.J. (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet31, 33—6.
28.
Ponder, B.A.J. (2001). Cancer genetics. Nature411, 336—41.
29.
Tanner, M.M., Grenman, S., Koul, A., Johannsson, O., Meltzer, P., Pejovic, T., Borg, A., and Isola, J.J. (2000). Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res6, 1833—39.
30.
Tripodis, N., Hart, A.A., Fijneman, R.J., and Demant, P. (2001). Complexity of lung cancermodifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst93, 1484—91.
31.
van Wezel, T., Ruivenkamp, C.A., Stassen, A.P., Moen, C.J., and Demant, P. (1999). Four new colon cancer susceptibility loci, Scc6 to Scc9 in the mouse. Cancer Res59, 4216—8.
32.
van Wezel, T., Stassen, A.P., Moen, C.J., Hart, A.A., van der Valk, M.A., and Demant, P. (1996). Gene interaction and single gene effects in colon tumor susceptibility in mice. Nat Genet14, 468—70.
33.
Wright, A.F., and Hastie, N.D. (2001). Complex genetic diseases: controversy over the Croesus code. Genome Biol2, Comment 2007.
